BIOMARKER PORTFOLIO
Validated analysis pipelines
From validated EEG endpoints to personalised computational brain models — co-defined with your clinical and regulatory teams.
Disclaimer: Services and technologies described here are provided by Neuroelectrics in collaboration with selected partners, including Neuronostics, Starlab, and Clouds of Care. Certain components, solutions, and services are provided by partners, who are fully responsible for their execution, delivery, and regulatory compliance.
T1 - DISEASE SPECIFIC
Primary & Secondary Endpoints
Epilepsy · Neurology
-
EEG Spectral & Signal Dynamics — % change across Delta, Theta, Alpha, Beta, Gamma
-
Neural Connectivity & Coupling (CFC, HFOs, functional connectivity)
-
Epileptiform Activity — spikes, slow-wave complexes, motor seizures
-
Ictal vs. Interictal state tracking
T2 — Cognitive & Mental Health
Pharmacodynamic Endpoints
Neurodevelopment · Mood · Cognition
-
ASSR, N2, P300, MMN, CNV (ERPs), Theta/Alpha Ratios
-
Working memory, attention & cognitive workload
-
Spectral power & Delta–Beta coupling
-
Resting-state functional connectivity
T3 — Exploratory
Mechanistic Markers
All CNS Indications
-
Entropy & fractal dimension
-
Lempel-Ziv Complexity
-
Network clustering coefficient & global efficiency
-
Custom mechanistic markers
END-TO-END TRIAL SUPPORT
One team runs the full EEG programme
From site readiness to data delivery — we own every step.
01
Protocol Development
Protocol design, endpoint definition, patient selection and stratification support from day one.
02
Hardware Delivery
Plug-and-play kits, pre-configured and trial-ready — delivered directly to each site.
03
Live Site & Staff Training
Our team trains every site live — tailored to your protocol, your staff, your patient population.
04
<10 min Setup & Signal Check
Automated signal quality check — green light in 5–10 minutes, no EEG expertise needed at bedside.
05
Patient Continues Their Day
Comfortable and wireless — in-clinic or at home, patients can go about daily activities or sleep wearing it.
06
Data Analysis & Statistics
Full data pipeline — collection, QC, transfer and audit-ready delivery to your statistics team.
WHY NEUROELECTRICS
Hardware, clinical operations and brain analytics — under one roof
For 25 years, we have combined PhD-level expertise with a full-stack approach to neuro-innovation, bridging the gap between groundbreaking research and clinical execution.
The Enobio Dx (FDA-cleared) and Enobio 8, 20, 32 (CE-marked) devices have been extensively validated across 100+ human trials spanning multiple CNS indications, in both clinical and home settings.
Robust Hardware
01
PhD-level teams with 25 years of neuro-innovation, bridging groundbreaking research and clinical execution across Epilepsy, Depression and beyond.
Biomarker Expertise
02
We design the hardware, publish the research, and sponsor our own clinical trials — your ally across all trial phases and delivery models.
End-to-End Accountability
03
Phase 1 · Phase 2 · Phase 3 · Phase 4 · RWE · Decentralized & Hybrid Trials
Present in 74 countries across Europe, North America, Latin America, Asia, Africa & Australia
EEG Biomarker Analytics
Specialists in AI-powered EEG biomarker analysis, providing validated software tools for clinical trial endpoints and patient stratification.
Neurotechnology & Research
A leading neurotechnology company contributing expertise in brain stimulation, advanced EEG analysis, and personalised brain modelling.
Decentralized Trial Delivery
Enabling remote and decentralized trial execution, extending EEG data collection beyond the clinic into patients' everyday environments.
Disclaimer: Services and technologies described here are provided by Neuroelectrics in collaboration with selected partners, including Neuronostics, Starlab, and Clouds of Care. Certain components, solutions, and services are provided by partners, who are fully responsible for their execution, delivery, and regulatory compliance.
OUR PARTNERS
Delivering together with selected specialists
We collaborate with leading partners to extend our capabilities across biomarker analysis, neurotechnology, and patient-centric care delivery.
